For instance, hydrogel nanomaterials employed in continuous subcutaneous insulin infusion (CSII) have shown improvements in blood glucose control and reduced therapeutic time in pediatric patients with type 1 diabetes mellitus [68]. Here, INS is linked to type 1 diabetes mellitus.